JP2013508385A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013508385A5 JP2013508385A5 JP2012535333A JP2012535333A JP2013508385A5 JP 2013508385 A5 JP2013508385 A5 JP 2013508385A5 JP 2012535333 A JP2012535333 A JP 2012535333A JP 2012535333 A JP2012535333 A JP 2012535333A JP 2013508385 A5 JP2013508385 A5 JP 2013508385A5
- Authority
- JP
- Japan
- Prior art keywords
- oxo
- methoxy
- chromene
- carboxamide
- propyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 54
- 229910052739 hydrogen Inorganic materials 0.000 claims 41
- 239000001257 hydrogen Substances 0.000 claims 41
- 150000002431 hydrogen Chemical class 0.000 claims 22
- 229910052736 halogen Inorganic materials 0.000 claims 21
- 150000002367 halogens Chemical class 0.000 claims 21
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 19
- NKCLIAPKIOWPQI-UHFFFAOYSA-N 7-methoxy-n-(2-methyl-4-sulfamoylphenyl)-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(S(N)(=O)=O)C=C1C NKCLIAPKIOWPQI-UHFFFAOYSA-N 0.000 claims 10
- 150000001875 compounds Chemical class 0.000 claims 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 8
- XDJBAFPKRDAYNN-UHFFFAOYSA-N n-(2-ethylpyridin-3-yl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CN=C1CC XDJBAFPKRDAYNN-UHFFFAOYSA-N 0.000 claims 8
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 7
- XMUJIPSGSVIHIW-SFHVURJKSA-N (3s)-3-amino-4-[4-[(7-methoxy-2-oxo-8-propylchromene-3-carbonyl)amino]-3-methylanilino]-4-oxobutanoic acid Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(NC(=O)[C@@H](N)CC(O)=O)C=C1C XMUJIPSGSVIHIW-SFHVURJKSA-N 0.000 claims 5
- RUDTYSGXBOPGQW-LJQANCHMSA-N (4r)-4-amino-5-[4-[(7-methoxy-2-oxo-8-propylchromene-3-carbonyl)amino]-3-methylanilino]-5-oxopentanoic acid Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(NC(=O)[C@H](N)CCC(O)=O)C=C1C RUDTYSGXBOPGQW-LJQANCHMSA-N 0.000 claims 5
- YFHRKOQRAMTMJH-UHFFFAOYSA-N 7,8-diethoxy-n-(2-methyl-4-sulfamoylphenyl)-2-oxochromene-3-carboxamide Chemical compound O=C1OC2=C(OCC)C(OCC)=CC=C2C=C1C(=O)NC1=CC=C(S(N)(=O)=O)C=C1C YFHRKOQRAMTMJH-UHFFFAOYSA-N 0.000 claims 5
- AWHRYVRERVXYJG-UHFFFAOYSA-N 7,8-diethoxy-n-[4-(methanesulfonamido)-2-(trifluoromethyl)phenyl]-2-oxochromene-3-carboxamide Chemical compound O=C1OC2=C(OCC)C(OCC)=CC=C2C=C1C(=O)NC1=CC=C(NS(C)(=O)=O)C=C1C(F)(F)F AWHRYVRERVXYJG-UHFFFAOYSA-N 0.000 claims 5
- ZLQHVRUEVDLCTM-UHFFFAOYSA-N 7-methoxy-2-oxo-8-propyl-n-[2-(trifluoromethyl)pyridin-3-yl]chromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CN=C1C(F)(F)F ZLQHVRUEVDLCTM-UHFFFAOYSA-N 0.000 claims 5
- WGTSLOPIFXMGCD-UHFFFAOYSA-N 7-methoxy-n-(2-methoxypyridin-3-yl)-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CN=C1OC WGTSLOPIFXMGCD-UHFFFAOYSA-N 0.000 claims 5
- RVTGAAIKWTUHCA-UHFFFAOYSA-N 7-methoxy-n-(2-methylpyridin-3-yl)-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CN=C1C RVTGAAIKWTUHCA-UHFFFAOYSA-N 0.000 claims 5
- 125000000623 heterocyclic group Chemical group 0.000 claims 5
- WBGRUXPFQJAYAE-UHFFFAOYSA-N n-(2-bromo-4-sulfamoylphenyl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(S(N)(=O)=O)C=C1Br WBGRUXPFQJAYAE-UHFFFAOYSA-N 0.000 claims 5
- PYRZKFBGDCLWKA-UHFFFAOYSA-N n-(2-bromopyridin-3-yl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CN=C1Br PYRZKFBGDCLWKA-UHFFFAOYSA-N 0.000 claims 5
- LKKRZVXANCKBMN-UHFFFAOYSA-N n-(2-chloro-4-sulfamoylphenyl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(S(N)(=O)=O)C=C1Cl LKKRZVXANCKBMN-UHFFFAOYSA-N 0.000 claims 5
- PPCGAUUHIZBQBZ-UHFFFAOYSA-N n-(2-chloropyridin-3-yl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CN=C1Cl PPCGAUUHIZBQBZ-UHFFFAOYSA-N 0.000 claims 5
- CMGHANZFDCUKLR-UHFFFAOYSA-N n-(4-hydroxy-2-methylphenyl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(O)C=C1C CMGHANZFDCUKLR-UHFFFAOYSA-N 0.000 claims 5
- QLPYUWGDRIETKX-UHFFFAOYSA-N n-[4-(methanesulfonamido)-2-(trifluoromethyl)phenyl]-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(NS(C)(=O)=O)C=C1C(F)(F)F QLPYUWGDRIETKX-UHFFFAOYSA-N 0.000 claims 5
- WORBNZQIKVAUHD-UHFFFAOYSA-N n-[4-(methanesulfonamido)-2-methylphenyl]-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(NS(C)(=O)=O)C=C1C WORBNZQIKVAUHD-UHFFFAOYSA-N 0.000 claims 5
- MQZHNBNUESVTAF-UHFFFAOYSA-N n-[4-acetamido-2-(trifluoromethyl)phenyl]-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(NC(C)=O)C=C1C(F)(F)F MQZHNBNUESVTAF-UHFFFAOYSA-N 0.000 claims 5
- GBFCZNHXFLLWCX-UHFFFAOYSA-N n-[4-hydroxy-2-(trifluoromethyl)phenyl]-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(O)C=C1C(F)(F)F GBFCZNHXFLLWCX-UHFFFAOYSA-N 0.000 claims 5
- AHUKBXBEQVAPBO-UHFFFAOYSA-N n-[6-(methanesulfonamido)-2-methylpyridin-3-yl]-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(NS(C)(=O)=O)N=C1C AHUKBXBEQVAPBO-UHFFFAOYSA-N 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 claims 4
- 208000027418 Wounds and injury Diseases 0.000 claims 4
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 claims 4
- 230000006378 damage Effects 0.000 claims 4
- 208000014674 injury Diseases 0.000 claims 4
- SXUJCMLUKCPOQB-UHFFFAOYSA-N n-[4-(methanesulfonamido)-2-methoxyphenyl]-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(NS(C)(=O)=O)C=C1OC SXUJCMLUKCPOQB-UHFFFAOYSA-N 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- CWULJNQDUNLNDV-UHFFFAOYSA-N 7-methoxy-2-oxo-8-propyl-n-(4-sulfamoylphenyl)chromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(S(N)(=O)=O)C=C1 CWULJNQDUNLNDV-UHFFFAOYSA-N 0.000 claims 3
- OQGSMEKXDGUYGI-UHFFFAOYSA-N 7-methoxy-2-oxo-8-propyl-n-[2-(trifluoromethoxy)phenyl]chromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CC=C1OC(F)(F)F OQGSMEKXDGUYGI-UHFFFAOYSA-N 0.000 claims 3
- LFLVZDAQVYLTCG-UHFFFAOYSA-N 7-methoxy-2-oxo-8-propyl-n-[2-(trifluoromethyl)phenyl]chromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CC=C1C(F)(F)F LFLVZDAQVYLTCG-UHFFFAOYSA-N 0.000 claims 3
- HBVMOPHHBLLBBL-UHFFFAOYSA-N 7-methoxy-2-oxo-8-propyl-n-[3-(trifluoromethyl)pyridin-4-yl]chromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=NC=C1C(F)(F)F HBVMOPHHBLLBBL-UHFFFAOYSA-N 0.000 claims 3
- TYMTVCVZIZRYCD-UHFFFAOYSA-N 7-methoxy-n-(2-methyl-4-sulfamoylphenyl)-2-oxo-8-propan-2-yloxychromene-3-carboxamide Chemical compound O=C1OC2=C(OC(C)C)C(OC)=CC=C2C=C1C(=O)NC1=CC=C(S(N)(=O)=O)C=C1C TYMTVCVZIZRYCD-UHFFFAOYSA-N 0.000 claims 3
- UWFNLFSFXRZEDL-UHFFFAOYSA-N 8-ethoxy-7-methoxy-2-oxo-n-[2-(trifluoromethyl)pyridin-3-yl]chromene-3-carboxamide Chemical compound O=C1OC=2C(OCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CN=C1C(F)(F)F UWFNLFSFXRZEDL-UHFFFAOYSA-N 0.000 claims 3
- HCYBNWMYOVXHEN-UHFFFAOYSA-N 8-ethoxy-7-methoxy-n-(2-methyl-4-sulfamoylphenyl)-2-oxochromene-3-carboxamide Chemical compound O=C1OC=2C(OCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(S(N)(=O)=O)C=C1C HCYBNWMYOVXHEN-UHFFFAOYSA-N 0.000 claims 3
- UPSMEWJCKGINAV-UHFFFAOYSA-N [3-chloro-4-[(7-methoxy-2-oxo-8-propylchromene-3-carbonyl)amino]phenyl]boronic acid Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(B(O)O)C=C1Cl UPSMEWJCKGINAV-UHFFFAOYSA-N 0.000 claims 3
- RJASNKXSDPCQFI-UHFFFAOYSA-N [4-[(7-methoxy-2-oxo-8-propylchromene-3-carbonyl)amino]-3-methylphenyl]phosphonic acid Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(P(O)(O)=O)C=C1C RJASNKXSDPCQFI-UHFFFAOYSA-N 0.000 claims 3
- 150000001299 aldehydes Chemical class 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 208000027866 inflammatory disease Diseases 0.000 claims 3
- OLTQZVZQPRTXCK-UHFFFAOYSA-N n-(2-bromophenyl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CC=C1Br OLTQZVZQPRTXCK-UHFFFAOYSA-N 0.000 claims 3
- MPHJLIUHCGDFSW-UHFFFAOYSA-N n-(2-ethylphenyl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CC=C1CC MPHJLIUHCGDFSW-UHFFFAOYSA-N 0.000 claims 3
- OUNWBTAPLPTHBE-UHFFFAOYSA-N n-(3-chloropyridin-4-yl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=NC=C1Cl OUNWBTAPLPTHBE-UHFFFAOYSA-N 0.000 claims 3
- ATLWOZNXBZCXBT-UHFFFAOYSA-N n-(4-acetamido-2-methylphenyl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(NC(C)=O)C=C1C ATLWOZNXBZCXBT-UHFFFAOYSA-N 0.000 claims 3
- VIVCQZNCRYMURD-UHFFFAOYSA-N n-[2-(difluoromethoxy)phenyl]-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CC=C1OC(F)F VIVCQZNCRYMURD-UHFFFAOYSA-N 0.000 claims 3
- 238000001356 surgical procedure Methods 0.000 claims 3
- 208000006820 Arthralgia Diseases 0.000 claims 2
- -1 diastereoisomers Chemical class 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- 230000029663 wound healing Effects 0.000 claims 2
- PYZTVFPPTAGDBT-UHFFFAOYSA-N 3-[[4-[(7-methoxy-2-oxo-8-propylchromene-3-carbonyl)amino]-3-methylphenyl]sulfonylamino]propanoic acid Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(S(=O)(=O)NCCC(O)=O)C=C1C PYZTVFPPTAGDBT-UHFFFAOYSA-N 0.000 claims 1
- NCOSSPBRMMNNBZ-UHFFFAOYSA-N 7-methoxy-2-oxo-8-propan-2-yloxy-n-[2-(trifluoromethyl)phenyl]chromene-3-carboxamide Chemical compound O=C1OC2=C(OC(C)C)C(OC)=CC=C2C=C1C(=O)NC1=CC=CC=C1C(F)(F)F NCOSSPBRMMNNBZ-UHFFFAOYSA-N 0.000 claims 1
- OSNPYWDOSPYMKB-UHFFFAOYSA-N 7-methoxy-2-oxo-8-propan-2-yloxy-n-[2-(trifluoromethyl)pyridin-3-yl]chromene-3-carboxamide Chemical compound O=C1OC2=C(OC(C)C)C(OC)=CC=C2C=C1C(=O)NC1=CC=CN=C1C(F)(F)F OSNPYWDOSPYMKB-UHFFFAOYSA-N 0.000 claims 1
- NRBGRNSVXHQIDM-UHFFFAOYSA-N 7-methoxy-2-oxo-8-propyl-n-(2-propylphenyl)chromene-3-carboxamide Chemical compound CCCC1=CC=CC=C1NC(=O)C1=CC2=CC=C(OC)C(CCC)=C2OC1=O NRBGRNSVXHQIDM-UHFFFAOYSA-N 0.000 claims 1
- GGFZKDUJSVUAAS-UHFFFAOYSA-N 7-methoxy-2-oxo-8-propyl-n-[4-(pyrrolidin-3-ylamino)phenyl]chromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC(C=C1)=CC=C1NC1CCNC1 GGFZKDUJSVUAAS-UHFFFAOYSA-N 0.000 claims 1
- ISIILKKXLMQZHJ-UHFFFAOYSA-N 7-methoxy-2-oxo-8-propyl-n-[4-sulfamoyl-2-(trifluoromethyl)phenyl]chromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(S(N)(=O)=O)C=C1C(F)(F)F ISIILKKXLMQZHJ-UHFFFAOYSA-N 0.000 claims 1
- TUKSXTIVZJKEKW-UHFFFAOYSA-N 7-methoxy-2-oxo-8-propyl-n-pyridin-3-ylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CN=C1 TUKSXTIVZJKEKW-UHFFFAOYSA-N 0.000 claims 1
- GXYFIRQILLOEBQ-UHFFFAOYSA-N 7-methoxy-2-oxo-8-propyl-n-pyridin-4-ylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=NC=C1 GXYFIRQILLOEBQ-UHFFFAOYSA-N 0.000 claims 1
- SINYPPASKWIFSG-UHFFFAOYSA-N 7-methoxy-2-oxo-n-[4-(piperidin-2-ylmethylamino)phenyl]-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC(C=C1)=CC=C1NCC1CCCCN1 SINYPPASKWIFSG-UHFFFAOYSA-N 0.000 claims 1
- ILRCIVHDFGDFPH-UHFFFAOYSA-N 7-methoxy-2-oxo-n-[4-(piperidin-3-ylamino)phenyl]-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC(C=C1)=CC=C1NC1CCCNC1 ILRCIVHDFGDFPH-UHFFFAOYSA-N 0.000 claims 1
- BQWOTCCYTUXCFA-UHFFFAOYSA-N 7-methoxy-2-oxo-n-[4-(piperidin-3-ylmethylamino)phenyl]-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC(C=C1)=CC=C1NCC1CCCNC1 BQWOTCCYTUXCFA-UHFFFAOYSA-N 0.000 claims 1
- HPZYHKCYYQFJOF-UHFFFAOYSA-N 7-methoxy-n-(2-methoxyphenyl)-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CC=C1OC HPZYHKCYYQFJOF-UHFFFAOYSA-N 0.000 claims 1
- BYSNZIZAKOHOAW-UHFFFAOYSA-N 7-methoxy-n-(2-methylphenyl)-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CC=C1C BYSNZIZAKOHOAW-UHFFFAOYSA-N 0.000 claims 1
- VCTQOVLQQGIXOQ-UHFFFAOYSA-N 7-methoxy-n-(2-methylpyridin-3-yl)-2-oxo-8-propan-2-yloxychromene-3-carboxamide Chemical compound O=C1OC2=C(OC(C)C)C(OC)=CC=C2C=C1C(=O)NC1=CC=CN=C1C VCTQOVLQQGIXOQ-UHFFFAOYSA-N 0.000 claims 1
- IYNGBTMWYNYEEC-UHFFFAOYSA-N 7-methoxy-n-(2-methylsulfanylphenyl)-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CC=C1SC IYNGBTMWYNYEEC-UHFFFAOYSA-N 0.000 claims 1
- YAWLMRDQYLGVKG-UHFFFAOYSA-N 7-methoxy-n-(3-methylpyridin-2-yl)-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=NC=CC=C1C YAWLMRDQYLGVKG-UHFFFAOYSA-N 0.000 claims 1
- XSXJNEQUWLJUPS-UHFFFAOYSA-N 7-methoxy-n-(3-methylpyridin-4-yl)-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=NC=C1C XSXJNEQUWLJUPS-UHFFFAOYSA-N 0.000 claims 1
- OFYIJONCOOYTEO-UHFFFAOYSA-N 7-methoxy-n-[2-methyl-4-(methylsulfamoyl)phenyl]-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(S(=O)(=O)NC)C=C1C OFYIJONCOOYTEO-UHFFFAOYSA-N 0.000 claims 1
- FVEJGQHYMNHDBY-UHFFFAOYSA-N 7-methoxy-n-[2-methyl-4-(methylsulfonylmethyl)phenyl]-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(CS(C)(=O)=O)C=C1C FVEJGQHYMNHDBY-UHFFFAOYSA-N 0.000 claims 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 1
- NRTHJBQQHIOGRJ-UHFFFAOYSA-N 8-ethoxy-7-methoxy-2-oxo-n-[2-(trifluoromethyl)phenyl]chromene-3-carboxamide Chemical compound O=C1OC=2C(OCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CC=C1C(F)(F)F NRTHJBQQHIOGRJ-UHFFFAOYSA-N 0.000 claims 1
- VIHTWMCPNIWCRD-UHFFFAOYSA-N 8-ethoxy-7-methoxy-n-(2-methylpyridin-3-yl)-2-oxochromene-3-carboxamide Chemical compound O=C1OC=2C(OCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CN=C1C VIHTWMCPNIWCRD-UHFFFAOYSA-N 0.000 claims 1
- STFPIVSYKOUENW-UHFFFAOYSA-N 8-ethyl-7-methoxy-n-(2-methyl-4-sulfamoylphenyl)-2-oxochromene-3-carboxamide Chemical compound O=C1OC=2C(CC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(S(N)(=O)=O)C=C1C STFPIVSYKOUENW-UHFFFAOYSA-N 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 206010003645 Atopy Diseases 0.000 claims 1
- 206010003694 Atrophy Diseases 0.000 claims 1
- 208000023328 Basedow disease Diseases 0.000 claims 1
- 208000010392 Bone Fractures Diseases 0.000 claims 1
- KWNCOOWERVGCBT-UHFFFAOYSA-N CCCc1c(OC)ccc2cc(C(=O)Nc3ccc(CS(O)(=O)=O)cc3C)c(=O)oc12 Chemical compound CCCc1c(OC)ccc2cc(C(=O)Nc3ccc(CS(O)(=O)=O)cc3C)c(=O)oc12 KWNCOOWERVGCBT-UHFFFAOYSA-N 0.000 claims 1
- 208000033379 Chorioretinopathy Diseases 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 1
- 206010014561 Emphysema Diseases 0.000 claims 1
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 208000015023 Graves' disease Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 206010062016 Immunosuppression Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 208000004852 Lung Injury Diseases 0.000 claims 1
- 206010027476 Metastases Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000022873 Ocular disease Diseases 0.000 claims 1
- 206010069385 Ocular ischaemic syndrome Diseases 0.000 claims 1
- 206010061323 Optic neuropathy Diseases 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 201000010183 Papilledema Diseases 0.000 claims 1
- 206010051246 Photodermatosis Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 206010037423 Pulmonary oedema Diseases 0.000 claims 1
- 206010063897 Renal ischaemia Diseases 0.000 claims 1
- 206010063837 Reperfusion injury Diseases 0.000 claims 1
- 201000001949 Retinal Vasculitis Diseases 0.000 claims 1
- 206010038886 Retinal oedema Diseases 0.000 claims 1
- 206010038926 Retinopathy hypertensive Diseases 0.000 claims 1
- 206010038933 Retinopathy of prematurity Diseases 0.000 claims 1
- 206010039705 Scleritis Diseases 0.000 claims 1
- 208000034189 Sclerosis Diseases 0.000 claims 1
- 206010040047 Sepsis Diseases 0.000 claims 1
- 208000000491 Tendinopathy Diseases 0.000 claims 1
- 206010043255 Tendonitis Diseases 0.000 claims 1
- 206010069363 Traumatic lung injury Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 208000024780 Urticaria Diseases 0.000 claims 1
- 206010046851 Uveitis Diseases 0.000 claims 1
- 208000000208 Wet Macular Degeneration Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 206010069351 acute lung injury Diseases 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 208000037883 airway inflammation Diseases 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 210000003423 ankle Anatomy 0.000 claims 1
- 230000003502 anti-nociceptive effect Effects 0.000 claims 1
- 210000001367 artery Anatomy 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 230000003143 atherosclerotic effect Effects 0.000 claims 1
- 230000037444 atrophy Effects 0.000 claims 1
- 201000004982 autoimmune uveitis Diseases 0.000 claims 1
- 230000005784 autoimmunity Effects 0.000 claims 1
- 230000004888 barrier function Effects 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000010247 contact dermatitis Diseases 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 208000011325 dry age related macular degeneration Diseases 0.000 claims 1
- 230000004761 fibrosis Effects 0.000 claims 1
- 238000002682 general surgery Methods 0.000 claims 1
- 150000004677 hydrates Chemical class 0.000 claims 1
- 201000001948 hypertensive retinopathy Diseases 0.000 claims 1
- 230000001506 immunosuppresive effect Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 claims 1
- 208000012947 ischemia reperfusion injury Diseases 0.000 claims 1
- 206010023332 keratitis Diseases 0.000 claims 1
- 210000003127 knee Anatomy 0.000 claims 1
- 208000024765 knee pain Diseases 0.000 claims 1
- 231100000515 lung injury Toxicity 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000009401 metastasis Effects 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 206010028417 myasthenia gravis Diseases 0.000 claims 1
- 230000002107 myocardial effect Effects 0.000 claims 1
- VGESBQGDASZCTF-UHFFFAOYSA-N n-(2-chloro-5-fluoropyridin-3-yl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC(F)=CN=C1Cl VGESBQGDASZCTF-UHFFFAOYSA-N 0.000 claims 1
- STIAVADDLYIXHJ-UHFFFAOYSA-N n-(2-chloro-5-methylpyridin-3-yl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC(C)=CN=C1Cl STIAVADDLYIXHJ-UHFFFAOYSA-N 0.000 claims 1
- PSPZWTNBVGBCHA-UHFFFAOYSA-N n-(2-chlorophenyl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CC=C1Cl PSPZWTNBVGBCHA-UHFFFAOYSA-N 0.000 claims 1
- JGBAHEVRZABQFY-UHFFFAOYSA-N n-(2-cyanophenyl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CC=C1C#N JGBAHEVRZABQFY-UHFFFAOYSA-N 0.000 claims 1
- XVJPHSAXNYTQII-UHFFFAOYSA-N n-(2-fluorophenyl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CC=C1F XVJPHSAXNYTQII-UHFFFAOYSA-N 0.000 claims 1
- GXAHTQDFFOQKOM-UHFFFAOYSA-N n-(2-formylpyridin-3-yl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CN=C1C=O GXAHTQDFFOQKOM-UHFFFAOYSA-N 0.000 claims 1
- FZICGKIMNLWNJB-UHFFFAOYSA-N n-(3-chloropyridazin-4-yl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=NN=C1Cl FZICGKIMNLWNJB-UHFFFAOYSA-N 0.000 claims 1
- FCBCEWPTTVXDSN-UHFFFAOYSA-N n-(3-fluoro-2-methylphenyl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CC(F)=C1C FCBCEWPTTVXDSN-UHFFFAOYSA-N 0.000 claims 1
- YBNFGQYSORCZNB-UHFFFAOYSA-N n-(4-amino-2-methylphenyl)-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(N)C=C1C YBNFGQYSORCZNB-UHFFFAOYSA-N 0.000 claims 1
- YFROROQILIVLDO-UHFFFAOYSA-N n-[2-(furan-2-yl)phenyl]-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=CC=C1C1=CC=CO1 YFROROQILIVLDO-UHFFFAOYSA-N 0.000 claims 1
- OTVZOISESXYAIA-UHFFFAOYSA-N n-[2-chloro-4-(methanesulfonamido)phenyl]-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(NS(C)(=O)=O)C=C1Cl OTVZOISESXYAIA-UHFFFAOYSA-N 0.000 claims 1
- GPOVSJVTPSVQIW-UHFFFAOYSA-N n-[4-(hydroxymethyl)phenyl]-7-methoxy-2-oxo-8-propylchromene-3-carboxamide Chemical compound O=C1OC=2C(CCC)=C(OC)C=CC=2C=C1C(=O)NC1=CC=C(CO)C=C1 GPOVSJVTPSVQIW-UHFFFAOYSA-N 0.000 claims 1
- 208000004296 neuralgia Diseases 0.000 claims 1
- 208000021722 neuropathic pain Diseases 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 208000020911 optic nerve disease Diseases 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 230000011164 ossification Effects 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 230000010412 perfusion Effects 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 230000008845 photoaging Effects 0.000 claims 1
- 208000005333 pulmonary edema Diseases 0.000 claims 1
- 230000005855 radiation Effects 0.000 claims 1
- 201000011195 retinal edema Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000001568 sexual effect Effects 0.000 claims 1
- 230000009759 skin aging Effects 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- DUYSYHSSBDVJSM-KRWOKUGFSA-N sphingosine 1-phosphate Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)COP(O)(O)=O DUYSYHSSBDVJSM-KRWOKUGFSA-N 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 201000004415 tendinitis Diseases 0.000 claims 1
- 238000009423 ventilation Methods 0.000 claims 1
- 208000009935 visceral pain Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25423609P | 2009-10-23 | 2009-10-23 | |
| US61/254,236 | 2009-10-23 | ||
| PCT/US2010/053363 WO2011050054A2 (en) | 2009-10-23 | 2010-10-20 | Coumarin compounds as receptor modulators with therapeutic utility |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013508385A JP2013508385A (ja) | 2013-03-07 |
| JP2013508385A5 true JP2013508385A5 (enExample) | 2013-12-05 |
Family
ID=43569412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012535333A Pending JP2013508385A (ja) | 2009-10-23 | 2010-10-20 | 治療上有用な、受容体修飾薬としてのクマリン化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US9073888B2 (enExample) |
| EP (1) | EP2491023B1 (enExample) |
| JP (1) | JP2013508385A (enExample) |
| KR (1) | KR20120075481A (enExample) |
| CN (1) | CN102686574A (enExample) |
| BR (1) | BR112012009670A2 (enExample) |
| CA (1) | CA2778611A1 (enExample) |
| RU (1) | RU2012119249A (enExample) |
| WO (1) | WO2011050054A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
| US12478503B2 (en) | 2009-05-18 | 2025-11-25 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
| WO2011050054A2 (en) * | 2009-10-23 | 2011-04-28 | Allergan, Inc. | Coumarin compounds as receptor modulators with therapeutic utility |
| CN107868069A (zh) * | 2017-10-31 | 2018-04-03 | 山东新华制药股份有限公司 | 7‑羟基‑8‑甲基‑6‑硝基‑2‑氧‑2h‑苯并吡喃‑3‑羧酸的制备工艺 |
| CN107935976B (zh) * | 2017-11-13 | 2020-01-17 | 山东大学 | 香豆素酰胺衍生物及其应用 |
| EP3747471A4 (en) | 2018-02-02 | 2021-10-27 | Kyoto University | MEDICINE FOR PREVENTING OR TREATING OPHTHALMIC DISEASE ASSOCIATED WITH INTRAOCULAR NEOVASCULARIZATION AND / OR INCREASED VASCULAR PERMEABILITY |
| CN110713497A (zh) * | 2019-10-30 | 2020-01-21 | 成都海杰亚医药科技有限公司 | 一种Brigatinib的中间体2-氨基苯基二甲基氧化膦制备方法 |
| US12273086B2 (en) * | 2022-08-31 | 2025-04-08 | Apple Inc. | Adjustable radio-frequency splitter-combiner |
| CN116478173B (zh) * | 2023-04-20 | 2025-03-25 | 山西师范大学 | 一种靶向高尔基体监测极性的荧光探针及其制备与应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1506359A (zh) | 2002-12-05 | 2004-06-23 | �й�ҽѧ��ѧԺҩ���о��� | 新的香豆素酰胺衍生物及其制法和其药物组合物与用途 |
| AU2004234067B2 (en) * | 2003-04-30 | 2008-02-28 | Novartis Ag | Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
| WO2004096752A1 (en) * | 2003-04-30 | 2004-11-11 | Novartis Ag | Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| GB0607389D0 (en) * | 2006-04-12 | 2006-05-24 | Novartis Ag | Organic compounds |
| EP2109606A1 (en) * | 2007-02-02 | 2009-10-21 | Novartis Ag | Chromene s1p1 receptor antagonist |
| BRPI0814975A2 (pt) | 2007-08-08 | 2015-02-03 | Merck Serono Sa | Derivados de 6-amino-pirimidina-4-carboxamida e compostos relacionados que se ligam ao receptor de 1-fosfato de esfingosina (s1p) para o tratamento de esclerose múltipla |
| WO2011050054A2 (en) * | 2009-10-23 | 2011-04-28 | Allergan, Inc. | Coumarin compounds as receptor modulators with therapeutic utility |
-
2010
- 2010-10-20 WO PCT/US2010/053363 patent/WO2011050054A2/en not_active Ceased
- 2010-10-20 CN CN2010800587171A patent/CN102686574A/zh active Pending
- 2010-10-20 CA CA2778611A patent/CA2778611A1/en not_active Abandoned
- 2010-10-20 RU RU2012119249/04A patent/RU2012119249A/ru not_active Application Discontinuation
- 2010-10-20 US US13/502,980 patent/US9073888B2/en active Active
- 2010-10-20 KR KR1020127013124A patent/KR20120075481A/ko not_active Withdrawn
- 2010-10-20 BR BR112012009670A patent/BR112012009670A2/pt not_active IP Right Cessation
- 2010-10-20 EP EP10774074.8A patent/EP2491023B1/en not_active Not-in-force
- 2010-10-20 JP JP2012535333A patent/JP2013508385A/ja active Pending
-
2015
- 2015-06-03 US US14/729,969 patent/US9572792B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013508385A5 (enExample) | ||
| RU2012119249A (ru) | Соединения кумарина в качестве модуляторов рецепторов для терапевтического использования | |
| CN103443098B (zh) | 作为溶血磷脂酸受体的拮抗剂的化合物、组合物及其应用 | |
| JP2007502804A5 (enExample) | ||
| RU2013127637A (ru) | Индольные производные в качестве модуляторов рецепторов s1p | |
| RU2013129484A (ru) | Алкиновые и алкеновые производные в качестве модуляторов рецептора сфингозин 1-фосфата-1 | |
| RU2013129483A (ru) | Новые фениловые производные оксадиазола в качестве модуляторов рецептора сфингозин 1-фосфата (s1p) | |
| JP2013544821A (ja) | Ｓ１ｐ受容体モジュレーターとしての新規ホスホン酸 | |
| RU2013130022A (ru) | Новые бензиловые производные азетидина в качестве модуляторов рецептора сфингозин 1-фосфата (s1p) | |
| TWI694986B (zh) | 經取代之吡啶基-環烷基-羧酸、包含其之組合物及其用途 | |
| CA2865215A1 (en) | Phenoxy-azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators | |
| ES2515415T3 (es) | Derivados de 3-(4-((1H-imidazol-1-il)metil)fenil)-5-aril-1,2,4-oxadiazol como moduladores de receptores de la esfingosina-1-fosfato | |
| JP2014500264A (ja) | スフィンゴシン−１−リン酸（ｓ１ｐ）受容体モジュレーターとしての新規オキシム誘導体 | |
| JP2007518798A5 (enExample) | ||
| RU2013130021A (ru) | Новые алкеновые производные в качестве модуляторов рецептора сфингозин 1-фосфата (s1p) | |
| ATE404195T1 (de) | Verwendung von phenylbenzamide-derivaten zur behandlung von chronisch-obstruktiver lungenerkrankung (copd) | |
| RU2013128324A (ru) | Модуляторы рецепторов s1p | |
| JP2013544837A (ja) | スフィンゴシン−１−リン酸（ｓ１ｐ）受容体モジュレーターとしての新規オキシムアゼチジン誘導体 | |
| JP2009541383A5 (enExample) | ||
| RU2013150173A (ru) | Метиламинные производные бициклического фенила как модуляторы рецепторов сфингозин-1-фосфата |